Structure | Chemical Name | CAS | MF |
|
4-Methoxy-2-(piperidin-4-yloxy)pyridine dihydrochloride
|
1707580-78-6
|
C11H18Cl2N2O2
|
|
3-Cyclopropylpyridin-4-amine dihydrochloride
|
1707580-80-0
|
C8H12Cl2N2
|
|
tert-Butyl 2-cyclobutyl-4-oxo-1,3,8-triazaspiro[4.5]dec-1-ene-8-carboxylate
|
1707580-81-1
|
C16H25N3O3
|
|
tert-Butyl 4-bromo-2-oxospiro[indoline-3,4'-piperidine]-1'-carboxylate
|
1707580-82-2
|
C17H21BrN2O3
|
|
1-(4-Methoxypyridin-2-yl)piperazine trihydrochloride
|
1707580-86-6
|
C10H18Cl3N3O
|
|
3-Methyl-4-(pyrrolidin-3-yloxy)pyridinedihydrochloride
|
1707584-09-5
|
C10H16Cl2N2O
|
|
N2-Cyclopentylpyridine-2,5-diamine trihydrochloride
|
1707584-11-9
|
C10H18Cl3N3
|
|
[1-(2-Fluorobenzyl)-1H-imidazol-5-yl]methanamine hydrochloride
|
1707584-12-0
|
C11H13ClFN3
|
|
(4,4-Difluoro-1-methylcyclohexyl)methanamine hydrochloride
|
1707602-10-5
|
C8H16ClF2N
|
|
N-[3-(Trifluoromethyl)benzyl]piperidin-4-amine dihydrochloride
|
1707602-13-8
|
C13H18ClF3N2
|
|
N-[4-(Trifluoromethyl)benzyl]piperidin-4-amine dihydrochloride
|
1707602-17-2
|
C13H19Cl2F3N2
|
|
tert-Butyl 4-chloro-2-oxo-1,2-dihydrospiro[indole-3,4'-piperidine]-1'-carboxylat
|
1707602-35-4
|
C17H21ClN2O3
|
|
4-Cyclobutyl-1H-pyrazol-3-amine
|
1707602-39-8
|
C7H11N3
|
|
2-[1-(tert-Butoxycarbonyl)-4-(3-methoxyphenyl)piperidin-4-yl]acetic acid
|
1707602-52-5
|
C19H27NO5
|
|
2-Methoxy-4-(pyrrolidin-3-yloxy)pyridine hydrochloride
|
1707602-53-6
|
C10H15ClN2O2
|
|
5-Methoxy-2-(pyrrolidin-3-yloxy)pyrimidine hydrochloride
|
1707602-57-0
|
C9H14ClN3O2
|
|
2-(3-Methoxyphenyl)-1,3,8-triazaspiro[4.5]dec-1-en-4-one hydrochloride
|
1707602-59-2
|
C14H18ClN3O2
|
|
5-Fluoro-2-(piperidin-4-yloxy)pyridine hydrochloride
|
1707602-62-7
|
C10H14ClFN2O
|
|
3-(cyclopropylmethyl)pyrrolidine
|
1707604-64-5
|
C8H16ClN
|
|
6-Fluoro-3-(tetrahydro-2H-pyran-3-yl)-1H-indole
|
1707710-38-0
|
C13H14FNO
|
|
N-[2-(Trifluoromethyl)benzyl]piperidin-4-amine dihydrochloride
|
1707710-39-1
|
C13H19Cl2F3N2
|
|
1-Cyclobutyl-1H-imidazol-4-amine hydrochloride
|
1707710-40-4
|
C7H12ClN3
|
|
N-(Piperidin-4-yl)-3-(trifluoromethyl)pyridin-2-amine trihydrochloride
|
1707710-41-5
|
C11H17Cl3F3N3
|
|
4-(2-Chlorophenyl)piperidin-4-amine dihydrochloride
|
1707713-77-6
|
C11H16Cl2N2
|
|
5-Bromospiro[Indoline-3,4'-Piperidin]-2-One Hydrochloride
|
1707713-79-8
|
C12H14BrClN2O
|
|
3-Methyl-4-(piperidin-3-yloxy)pyridine dihydrochloride
|
1707713-82-3
|
C11H18Cl2N2O
|
|
2-Methyl-6-(piperidin-3-yloxy)pyridine dihydrochloride
|
1707714-08-6
|
C11H18Cl2N2O
|
|
4-Methoxy-2-(piperidin-3-yloxy)pyridine hydrochloride
|
1707714-44-0
|
C11H17ClN2O2
|
|
1-(tetrahydro-2H-thiopyran-4-yl)-1H-1,2,3-triazole-4-carboxylic acid
|
1707734-97-1
|
C8H11N3O2S
|
|
7-epi-6β-Ethyl Ursodeoxycholic Acid
|
1708092-13-0
|
C26H44O4
|
|
Parecoxib Impurity H
|
1708094-99-8
|
C22H23N3O7S2
|
|
Everolimus Ring-Opening Impurity
|
1708118-13-1
|
C53H83NO14
|
|
N,N-Dimethyl-2-(3,4,5-trifluorophenoxy)ethanamine
|
1708924-46-2
|
C10H12F3NO
|
|
2-(3,4-Difluorophenoxy)-N,N-dimethylethanamine
|
1708924-47-3
|
C10H13F2NO
|
|
SodiuM 3-chloro-4-Methylbenzoate
|
1708942-15-7
|
C8H8ClNaO2
|
|
sodiuM 2-fluoro-4-Methylbenzoate
|
1708942-19-1
|
C8H8FNaO2
|
|
FGF-401
|
1708971-55-4
|
C25H30N8O4
|
|
FGFR4-IN-1
|
1708971-72-5
|
C24H27N7O5
|
|
6-bromo-7-(dimethoxymethyl)-1,2,3,4-tetrahydro-1,8-naphthyridine
|
1708974-02-0
|
C11H15BrN2O2
|
|
2-amino-4-fluoro-cyanopyridine
|
1708974-11-1
|
C6H4FN3
|
|
4-Fluoro-5-iodo-pyridin-2-ylamine
|
1708974-12-2
|
C5H4FIN2
|
|
2-(dimethoxymethyl)-5,6,7,8-tetrahydro-1,8-naphthyridine-3-carbaldehyde
|
1708974-56-4
|
C12H16N2O3
|
|
6-amino-4-((2-methoxyethyl)amino)nicotinonitrile
|
1708975-10-3
|
C9H12N4O
|
|
1-((2-(dimethoxymethyl)-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)methyl)-4-methylpiperazin-2-one
|
1708975-38-5
|
C17H26N4O3
|
|
tert-butyl(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)carbamate
|
1708976-69-5
|
C14H20N4O3
|
|
tert-butyl-(4-chloro-5-cyanopyridin-2-yl)carbamate
|
1708976-70-8
|
C11H12ClN3O2
|
|
4-(BENZYLOXY)-3-CHLORO-5-FLUOROBENZALDEHYDE
|
1709785-15-8
|
C14H10ClFO2
|
|
5-Tert-Butyl 3-Ethyl 6,7-Dihydro-2H-Pyrazolo[4,3-C]Pyridine-3,5(4H)-Dicarboxylate
|
1709843-86-6
|
C14H21N3O4
|
|
MI-103 / MI-463 / MI-503 intermediate
|
1709863-43-3
|
C18H23F3N4O2S
|
|
Parecoxib Sodium Impurity 14
|
1709956-89-7
|
C19H18N2O4S
|
|
Parecoxib
|
1709956-95-5
|
C16H12ClNO3S
|
|
DHIQ-NHC-Mes
|
1710476-21-3
|
C35H38BF4N3OSi
|
|
(S)-THQphos
|
1710694-47-5
|
C29H22NO2P
|
|
5-Bromo-2-formyl-nicotinic acid methyl ester
|
1710703-03-9
|
C8H6BrNO3
|
|
4-bromo-2-fluoro-N-phenylbenzenesulfonamide
|
1711413-16-9
|
C12H9BrFNO2S
|
|
Tetrakis(4-hydroxybiphenyl)ethylene
|
1712454-96-0
|
C50H36O4
|
|
ARTICAINE IMPURITY A
|
1712677-79-6
|
C12H18N2O3S
|
|
6-Methoxy-N-(piperidin-4-yl)pyrimidin-4-amine dihydrochloride
|
1713160-69-0
|
C10H17ClN4O
|
|
tert-Butyl 4-amino-4-[3-(trifluoromethyl)phenyl]piperidine-1-carboxylate
|
1713160-77-0
|
C17H23F3N2O2
|
|
1-(Quinazolin-4-yl)azetidin-3-amine hydrochloride
|
1713160-84-9
|
C11H13ClN4
|
|
3-Methyl-2-(pyrrolidin-3-yloxy)pyridine hydrochloride
|
1713160-88-3
|
C10H15ClN2O
|
|
N2,N2-Dimethylpyridine-2,5-diamine trihydrochloride
|
1713160-90-7
|
C7H12ClN3
|
|
4-Methoxy-2-(piperidin-4-yloxy)pyrimidine hydrochloride
|
1713162-80-1
|
C10H16ClN3O2
|
|
tert-Butyl 2-isopropyl-4-oxo-1,3,8-triazaspiro[4.5]dec-1-ene-8-carboxylate
|
1713162-87-8
|
C15H25N3O3
|
|
2-Methoxy-6-(pyrrolidin-3-yloxy)pyridine dihydrochloride
|
1713162-92-5
|
C10H16Cl2N2O2
|
|
6-Bromo-3-cyclobutylpyrazolo[1,5-a]pyrimidine
|
1713162-94-7
|
C10H10BrN3
|
|
2-Cyclobutyl-3-methyl-1,3,8-triazaspiro[4.5]dec-1-en-4-one hydrochloride
|
1713162-99-2
|
C12H20ClN3O
|
|
1-(Cyclobutylmethyl)-1H-imidazol-4-aminehydrochloride
|
1713163-20-2
|
C8H14ClN3
|
|
N-(Piperidin-4-yl)-2-(trifluoromethyl)benzamide hydrochloride
|
1713163-21-3
|
C13H16ClF3N2O
|
|
tert-Butyl 4-amino-4-(cyclopropylmethyl)piperidine-1-carboxylate
|
1713163-27-9
|
C14H26N2O2
|
|
1-(4-Methoxyphenyl)-1H-imidazole-5-carboxylic acid
|
1713163-54-2
|
C11H10N2O3
|
|
[1-(3-Fluorobenzyl)-1H-imidazol-5-yl]methanamine hydrochloride
|
1713163-55-3
|
C11H13ClFN3
|
|
2-Ethyl-1,3,8-triazaspiro[4.5]dec-1-en-4-one hydrochloride
|
1713163-91-7
|
C9H16ClN3O
|
|
5-Methyl-4-(pyrrolidin-3-yloxy)pyrimidine hydrochloride
|
1713163-97-3
|
C9H14ClN3O
|
|
2-(2-Fluorophenyl)-1,3,8-triazaspiro[4.5]dec-1-en-4-one hydrochloride
|
1713163-98-4
|
C13H15ClFN3O
|
|
CM-4620
|
1713240-67-5
|
C19H11ClF3N3O3
|
|
6-BROMO-4-FLUOROQUINOLINE
|
1713240-89-1
|
C9H5BrFN
|
|
tert-butyl (S)-2-(5-chloro-1H-imidazol-2-yl)pyrrolidine-1-carboxylate
|
1713286-24-8
|
C12H18ClN3O2
|
|
methyl(S)-1-((S)-2-(5-chloro-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-ylcarbamate
|
1713286-26-0
|
C14H21ClN4O3
|
|
N-(2-Acetylphenyl)Heptanamide
|
1713577-53-7
|
C15H21NO2
|
|
2-{4-[5-(Trifluoromethyl)-1,3,4-thiadiazol-2-yl]piperazin-1-yl}ethanol
|
1713589-54-8
|
C9H13F3N4OS
|
|
2-(4-Cyclopropyl-6-oxopyrimidin-1(6H)-yl)acetic acid
|
1713714-07-8
|
C9H10N2O3
|
|
(R)-isopropyl 2-(((S)-(perfluorophenoxy)(phenoxy)phosphoryl)aMino)propanoate
|
1714114-25-6
|
C18H17F5NO5P
|
|
Propargyl--PEG3-phosphonic acid
|
1714139-62-4
|
C9H17O6P
|
|
Benzyl 2,9-Diazaspiro[5.5]Undecane-2-Carboxylate Hydrochloride Hydrochloride
|
1714144-91-8
|
C17H25ClN2O2
|
|
I-BRD9
|
1714146-59-4
|
C22H22F3N3O3S2
|
|
(3R,5S,E)-7-(4-(4-fluorophenyl)-2-((2-hydroxy-N,2-dimethylpropyl)sulfonamido)-6-isopropylpyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid
|
1714147-47-3
|
C25H36CaFN3O7S
|
|
Rosuvastatin
|
1714147-49-5
|
C29H42FN3O7S
|
|
Rosuvastatin EP impurity A
|
1714147-50-8
|
C25H34FN3NaO7S*
|
|
(2'S, 3'R)-Cabazitaxel
|
1714967-27-7
|
C45H57NO14
|
|
5F-ADB or 5F-MDMB-PINACA
|
1715016-75-3
|
C20H28FN3O3
|
|
Tert-Butyl 4-(3-Aminopyrazin-2-Yl)-2-Fluorobenzoate
|
1715031-88-1
|
C15H16FN3O2
|
|
ethyl(1R,3S,4S)-4-((tert-butyldimethylsilyl)oxy)-3-fluorocyclohexane-1-carboxylate
|
1715032-78-2
|
C15H29FO3Si
|
|
5-((1S,3S,4S)-4-((tert-butyldimethylsilyl)oxy)-3-fluorocyclohexyl)pyrazin-2-amine
|
1715032-85-1
|
C16H28FN3OSi
|
|
3-bromo-5-((1S,3S,4S)-4-((tert-butyldimethylsilyl)oxy)-3-fluorocyclohexyl)pyrazin-2-amine
|
1715032-86-2
|
C16H27BrFN3OSi
|
|
tert-butyl4-(3-amino-6-((1S,3S,4S)-4-((tert-butyldimethylsilyl)oxy)-3-fluorocyclohexyl)pyrazin-2-yl)-2-fluorobenzoate
|
1715032-87-3
|
C27H39F2N3O3Si
|
|
4-(3-amino-6-((1S,3S,4S)-3-fluoro-4-hydroxycyclohexyl)pyrazin-2-yl)-2-fluoro benzoic acid
|
1715032-88-4
|
C17H17F2N3O3
|
|
4-bromo-5-methyl-1H-indazol-3-amine
|
1715912-74-5
|
C8H8BrN3
|
|
3-Bromo-5-FluorobenzoicAcid98%
|
1764548-70-2
|
C7H4BrFO2
|
|
1-(4-ISOPROPOXY-BENZOYL)-PYRROLIDINE-2-CARBOXYLIC ACID
|
1770751-65-9
|
C16H20O4
|